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Abstract
Communication between neoplastic cells and cells of their microenvironment is critical to
cancer progression. To investigate the role of cytoneme-mediated signaling as a mecha-
nism for distributing growth factor signaling proteins between tumor and tumor-associated
cells, we analyzed EGFR and RET Drosophila tumor models and tested several genetic
loss-of-function conditions that impair cytoneme-mediated signaling. Neuroglian, capricious,
Irk2, SCAR, and diaphanous are genes that cytonemes require during normal development.
Neuroglian and Capricious are cell adhesion proteins, Irk2 is a potassium channel, and
SCAR and Diaphanous are actin-binding proteins, and the only process to which they are
known to contribute jointly is cytoneme-mediated signaling. We observed that diminished
function of any one of these genes suppressed tumor growth and increased organism sur-
vival. We also noted that EGFR-expressing tumor discs have abnormally extensive trachea-
tion (respiratory tubes) and ectopically express Branchless (Bnl, a FGF) and FGFR. Bnl is a
known inducer of tracheation that signals by a cytoneme-mediated process in other con-
texts, and we determined that exogenous over-expression of dominant negative FGFR sup-
pressed tumor growth. Our results are consistent with the idea that cytonemes move
signaling proteins between tumor and stromal cells and that cytoneme-mediated signaling is
required for tumor growth and malignancy.
Author summary
The growth of many types of tumors depend on productive interactions with stromal,
non-tumor neighbors, and although there is evidence that tumor and stromal cells
exchange signaling proteins and growth factors that they produce, the mechanism by
which these proteins move between the signaling cells has not been investigated and is not
known. Our previous work has shown that normal cells make transient chemical synapses
at sites where specialized filopodia called cytonemes contact signaling partners, and in
this work we explore the possibility that tumors use the same mechanism to communicate
with stromal cells. We show that cytoneme-mediated signaling is essential for growth of
Drosophila tumors that model human EGFR over-expression and RET-driven disease.
Remarkably, inhibition of cytonemes cures flies of lethal tumors.
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Introduction
Human tumors include transformed tumor cells, blood vessels, immune response cells, and
stromal cells that together with the extracellular matrix (ECM) constitute a “tumor microenvi-
ronment” [1]. The tumor microenvironment is essential for oncogenesis, cell survival, tumor
progression, invasion and metastasis [2,3], and its stromal cells produce key drivers of tumori-
genesis. Known drivers are growth factors (e.g. HGF, FGF, EGF, IGF-1, TGF-β and Wnts),
cytokines (e.g. IL-6, SDF-1) and pro-angiogenic factors (e.g. VEGF). It is not known if these
proteins function as autocrine, juxtacrine, or paracrine signals, nor is it known how they
might move into or within the tumor microenvironment.
Studies of tumor models in Drosophila exploit the experimental attributes of the fly that pro-
vide uniquely powerful ways to investigate tumorigenesis [4]. We tested two models for the roles
of cytonemes. Cytonemes are specialized, actin-based filopodia that extend between cells that pro-
duce and secrete signaling proteins and cells that receive them. The signaling proteins move along
cytonemes and exchange at transient synapses that form where cytonemes contact target cells.
These synapses are similar to neuronal synapses in constitution, structure and function [5–7], and
are necessary for paracrine FGF/Bnl, BMP/Dpp, Hedgehog, Wnt/Wingless (Wnt/Wg), and
Notch signaling during normal development of Drosophila epithelial tissues [5,7–9].
EGFR activating mutations are drivers of several types of human cancers [10]. However, ele-
vated EGFR expression of wild type EGFR is not sufficient for tumorigenesis, and additional
genetic changes are necessary, such as over-expression of Perlecan, a heparan sulfate proteoglycan
(HSPG) component of the ECM [11]. In Drosophila, ectopic over-expression of Perlecan and
EGFR in epithelial cells of the wing imaginal disc drives tumorigenesis [12]. Growth and metastasis
of the epithelial cells require crosstalk with closely associated mesenchymal myoblasts, which also
proliferate abnormally when Perlecan and EGFR are over-expressed in epithelial neighbors. The
crosstalk includes BMP/Dpp signaling from the epithelial cells to the mesenchymal myoblasts [12].
The RET gene is the primary oncogenic driver for MEN2 (multiple endocrine neoplasia
type 2) syndrome. MEN2 is characterized by several types of neoplastic transformations,
including an aggressive thyroid cancer called medullary thyroid carcinoma (MTC). A fly
model that overexpresses RETMEN2 phenocopies aspects of the aberrant signaling in MEN2-re-
lated tumors, such as activation of the SRC signal transduction pathway, which promotes
migration and metastasis of tumorigenic cells. The relevance of the fly model has been estab-
lished by screens for small molecule suppressors of Drosophila tumors driven by RETMEN2
over-expression. Several compounds that were identified are more effective than the drugs that
are currently used for patients [13,14].
In the work presented here, we examined the role of cytoneme-mediated signaling in the
EGFR-Pcn and RETMEN2 models. Genetic inhibition of cytonemes by downregulation of five
genes that were shown previously to be essential in cytoneme-mediated signaling, reduced
tumor growth, and we describe genetic conditions that suppress lethality by as much as 60% in
the EGFR-Pcn tumor and by as much as 30% in the RETMEN2 tumor. Our results are consis-
tent with the possibility that cytoneme-mediated signaling is necessary for tumor growth and
that interfering with cytoneme-mediated tumor-stromal cell signaling might be a therapy for
tumor suppression.
Results
Tumor cells and stromal cells extend cytonemes
Most of the wing imaginal disc is a columnar epithelium that will generate the wing and cuticle
of the dorsal thorax of the adult fly. The disc also includes myoblasts that grow and spread
Tumor cytonemes
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over much of the dorsal basal surface of the columnar epithelium; these mesenchymal cells will
generate the flight muscles of the adult. Tracheal branches (respiratory tubes) also adjoin the
basal surface of the columnar epithelium, and one branch, the transverse connective, sprouts a
bud (the air sac primordium (ASP), Fig 1A) that initiates growth during the third instar
period. The ASP is dependent on Dpp and Bnl signaling proteins produced by the wing disc
[7]. The myoblasts relay Wg and Notch signaling between the disc and ASP [9]. Cytonemes
mediate and are essential for the Dpp, Bnl, Wg, and Notch signaling [15].
To investigate whether cytonemes are also essential in tumorigenesis, we tested a cancer
model that requires tumor-stroma interactions in which neoplastic transformation is driven
by interactions between the wing disc epithelial cells and myoblasts [12]. Overexpression of
wild type EGFR and Perlecan (pcn, a secreted heparan sulfate proteoglycan) in the columnar
epithelium drives proliferation of the genetically modified epithelial cells, as well as their genet-
ically wild type myoblast neighbors. Tumorigenesis depends on Dpp signaling from the epithe-
lial cells to the myoblasts.
We first investigated if cytonemes are present in EGFR-Pcn overexpressing tumor cells. We
induced the EGFR-Pcn tumor model (with ap-Gal4, an epithelial cell-specific driver) together
with CD8:GFP, a membrane-tethered GFP protein (Fig 1C and 1D), and independently
expressed membrane-tethered mCherry in the myoblasts (with 1151-lexA, lexO-mCherry-
CAAX; a myoblast-specific driver). In this system, the epithelial cell membranes are marked
with GFP fluorescence and the myoblast membranes are marked with mCherry fluorescence.
We observed that, as previously reported [12], the EGFR-Pcn tumor induces overgrowth and
proliferation, producing multilayered masses of disorganized disc epithelial cells and myo-
blasts ([12], Fig 1D). Higher magnification imaging detected both epithelial cell cytonemes
and myoblast cytonemes. Some of the cytonemes appear to extend between the tumor and
mesenchymal populations (Fig 1E–1F’). These results show that tumor cells and tumor-associ-
ated cells extend cytoneme-like structures and are consistent with the possibility that cyto-
nemes may facilitate signaling between these cell populations.
To monitor the tracheal branches that are associated with the tumorous discs, we induced
the EGFR-Pcn tumor and labelled the trachea with membrane tethered GFP (with LHG lex-
O-CD2:GFP, a tracheal-specific driver [16]). In the EGFR-Pcn tumor discs, the associated tra-
chea were more extensive and branched than normal (Fig 1G and 1H). Their overgrowth was
presumably a response to the disc tumor.
Dpp localizes to tumor epithelial cell cytonemes
In normal development, Dpp produced by wing disc cells at the anterior/posterior compart-
ment border is transported by cytonemes to target cells in both the wing disc and ASP, and
cytoneme deficits caused by Capricious (Caps), Neuroglian (Nrg), or Diaphanous (Dia) loss-
of-function lead to developmental defects [7]. In the EGFR-Pcn tumor model, Dpp signals
from the genetically altered epithelial cells to drive myoblast expansion [12]. Dpp expression is
upregulated in the epithelial cells (Fig 2A and 2A’) and pMAD, the phosphorylated form of the
Dpp signal transducer MAD, is enriched in the myoblasts (Fig 2A” and 2A’”). This indication
of Dpp signal transduction in the myoblasts is consistent with previous results showing that
Dpp signaling in this stromal compartment is required for tumor growth [12].
To investigate how Dpp moves in the EGFR-Pcn model, we used CRISPR mutagenesis to
tag the endogenous Dpp protein with mCherry. mCherry was inserted at codon 465 as
described in [17]. Homozygous Dpp:mCherry flies that lack a wild type dpp gene are viable
and develop as wild type, indicating that the Dpp:mCherry chimera has normal function. We
induced the EGFR-Pcn tumor in Dpp:mCherry flies, and labeled the EGFR-Pcn tumor cells
Tumor cytonemes
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with CD8:GFP. Dpp:mCherry fluorescence was present in the cytonemes of the epithelial
tumor cells (Fig 2B, 2B’ and 2B”), consistent with the possibility that Dpp signaling is mediated
by cytonemes in the EGFR-Pcn tumor model.
Genetic suppression of tumor phenotypes
To assess the role of cytonemes in tumorigenesis, we examined discs in which cytonemes are
impaired. Downregulation of Nrg, Caps, SCAR, or dia decreases the number and length of
cytonemes, and decreases signaling in tracheal cells, myoblasts and wing disc cells [7,9,18].
Nrg and Caps are cell adhesion proteins and SCAR and Dia are actin-binding proteins.
Although severe loss-of-function conditions for Nrg, caps, SCAR or dia are lethal, the partial
Fig 1. Cytonemes in EGFR-Pcni tumor and tumor-associated cells. (A) Cartoon of a 3
rd instar larval wing disc with wing blade primordia (wbp), disc-associated
myoblasts (orange), trachea (white, outlined in blue) and air sac primordium (ASP), Dpp expressing cells (green stripe), Bnl expressing cells (blue circle). (B) Control wing
disc expressing CD8:GFP in dorsal driven epithelial cells (ap-Gal4; green), and mCherry:CAAX in myoblasts ((15B03-lexA; red). (C) Schematic representation of tumor
induction: animals developed for five days at 18˚C with Gal4 repressed by Gal80, were transferred to 29˚C to induce Gal4 and tumor growth for seven days (unless
indicated otherwise). (D-F) Unfixed EGFR-Pcn tumor model wing discs. (D) Wing disc with tumor cells (CD8:GFP; green) and myoblasts (mCherry:CAAX; red).
Genotype: ap-Gal4,UAS-psqRNAi/115B03-lexA,lexO-Cherry-CAAX;UAS-EGFR,tub-Gal80ts/UAS-CD8:GFP. Scale bars: 100μm. (E) Cytonemes in the tumor epithelial cells
(green, arrows); genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/UAS-CD8:GFP. (F-F’) Cytonemes in myoblasts (red, arrows) extend towards epithelial cells
(green); genotype: ap-Gal4,UAS-psqRNAi/115B03-lexA,lexO-Cherry-CAAX;UAS-EGFR,tub-Gal80ts/UAS-CD8:GFP; scale bars: 50μm. (G-H) Unfixed wing discs with
marked tracheal cells (green, arrows); (G) control, genotype: btl-LHG,lexO-CD2-GFP; (H) EGFR-Pcn tumor, genotype: ap-Gal4,UAS-psqRNAi/btl-LHG,lexO-CD2-GFP;
UAS-EGFR,tub-Gal80ts/+. Excessive tracheal growth and ectopic branches indicated by arrows; scale bars: 100μm.
https://doi.org/10.1371/journal.pgen.1008415.g001
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loss-of-function conditions we used and previously characterized do not perturb cell polarity,
cell viability, or cell cycle during normal development [7,9,19,20]. Previous studies of the wing
disc and associated tracheal cells and myoblasts identified cytonemes that either “send” signal-
ing proteins from producing cells or “receive” signaling proteins from target cells, and
reported cytonemes that link disc cells to each other or to tracheal cells or myoblasts [9,18,20–
22]. Available genetic tools can be used to impair cytoneme function but they do not distin-
guish among these types of cytonemes.
For the tumor discs with diminished Nrg, Caps, SCAR, or Dia, we compared disc morphol-
ogy, Dpp signaling (monitored by anti-pMad antibody staining), and myoblast distribution
(monitored by anti-Cut antibody staining, a marker of myoblasts [23]) in three types of wing
discs: control non-tumor discs, EGFR-Pcn tumor discs and EGFR-Pcn tumor discs that also
expressed CapsDN or RNAi constructs targeting Nrg, Dia, or SCAR. These genotypes were
generated from two crosses. In the first, EGFR-Pcn tumor discs were generated from a cross
between ap-Gal4,UAS-psqRNAi/CyO;UAS-EGFR,tub-Gal80ts and UAS-CD8:GFP that produces
equal numbers of animals with the tumor genotype and non-tumor controls that have the CyO
balancer and lack ap-Gal4,UAS-psqRNAi. The animals were incubated to the 2nd instar stage at
low temperature (18˚C) to permit repression of the transgenes by Gal80ts and were incubated
at non-permissive temperature (29˚C) thereafter (Fig 1C). The CyO control animals develop
to late 3rd instar within one day and eclose in approximately four days as curly wing adults. All
remaining animals developed tumors and were developmentally-delayed, and were analyzed
after seven days of culture at 29˚C. The second cross mated ap-Gal4,UAS-psqRNAi/CyO;
UAS-EGFR,tub-Gal80ts to flies with the respective “tester chromosome” carrying UAS-CapsDN
or UAS-RNAi, and were incubated with the same regimen involving removal of CyO balancer
adults. The remaining larvae had tumor phenotypes to varied degrees.
Tumor discs were misshapen and approximately 6.3 times larger than control discs, their
number of Cut-expressing cells increased by four times, and their anti-pMad staining was not
patterned normally (Fig 3A and 3B). In contrast, discs with tumor cells that expressed
NrgRNAi in addition to EGFR and Pcn were morphologically less distorted, only 1.8 times
Fig 2. Dpp signaling in the EGFR-Pcn tumor model. (A,A’,B) Unfixed wing discs showing the Dpp distribution. (A) Control disc with Dpp (red, arrow). Genotype: Dpp:
mCherry. Scale bar: 100μm. (A’) Disc with EGFR-Pcn tumor induced for 5 days expressing Dpp (red) in tumor cells. Genotype: ap-Gal4,UAS-psqRNAi/Dpp:mCherry;
UAS-EGFR,tub-Gal80ts/UAS-CD8:GFP. Arrows indicate Dpp up-regulation. (A”-A”’) EGFR-Pcn wing showing epithelial tumor cells (green) fixed and stained with α-
phosphorylated MAD (pMad, red) antibody to monitor Dpp signaling and α-Cut (blue) to label myoblasts. Genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/
UAS-CD8:GFP. Scale bar: 100μm. (A”’) Higher magnification image of the box area in (A”), scale bar: 50μm. (B-B”) Cytoneme (green) extending from epithelial tumor cell
(green) with Dpp:mCherry (red); arrow indicates Dpp:mCherry in cytoneme. Genotype: ap-Gal4,UAS-psqRNAi/Dpp:mCherry;UAS-EGFR,tub-Gal80ts/UAS-CD8:GFP. Scale
bar: 50μm.
https://doi.org/10.1371/journal.pgen.1008415.g002
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larger than controls, and the number and distribution of Cut-expressing cells was close to nor-
mal (Fig 3C and 3C’). In these animals, expression of EGFR, Pcn, and NrgRNAi is driven by
ap-Gal4 continuously after the second instar, but the noxious effects of NrgRNAi suppress the
tumor phenotype induced by EGFR and Pcn overexpression and are tolerated by the disc cells
in which NrgRNAi is expressed. The implication is that tumor cells are more sensitive to the
consequences of Nrg downregulation than are normal cells. Hyper-sensitivity to sub-lethal lev-
els of toxic conditions is a common hallmark of tumor cells.
Expression of CAPSDN, SCARRNAi, or diaRNAi in the epithelial cells of the EGFR-Pcn
model also reduced tumor growth, pMAD expression and number of Cut-expressing cells (Fig
3D–3F’). Expression of diaRNAi also suppressed excessive tracheation in the tumor discs (Fig
3S). To test whether the suppressive, ameliorative effects might be additive, we expressed
NrgRNAi and diaRNAi simultaneously in EGFR-Pcn tumor cells. We did not observe that the
degree of tumor suppression changed relative to expression of either NrgRNAi or diaRNAi
alone (Fig 3G). We also tested the roles of three genes that are essential for planar cell polarity
[24]: the dachsous (ds) and fat (ft) genes that encode cadherin family proteins, and four-jointed
(fj) that encodes a transmembrane kinase. Expression of dsRNAi, ftRNAi or fjRNAi does not
perturb cytoneme-mediated signaling between wing disc and tracheal cells [19], and expres-
sion of these RNAi lines in the tumor cells had no apparent effect on tumorigenesis (S2 Fig).
Fig 3H summarizes the growth suppression we observed in the genetic conditions we tested.
The presence of cytonemes in both the tumor columnar epithelial and mesenchymal myo-
blast cells, and the essential role of the myoblasts for tumor progression raises the possibility
that myoblast cytonemes might also play an essential role in tumorigenesis. To investigate the
role of myoblast cytonemes, we expressed diaRNAi (with 1151-lexA lexO-diaRNAi) in the
myoblasts of discs that overexpress EGFR and Pcn in the columnar epithelial cells. The mor-
phology, Dpp signaling pattern and myoblast growth characteristic of the EGFR-Pcn tumors
were suppressed (Fig 3I and 3I’). This result is consistent with the idea that the myoblasts sig-
nal to the epithelial tumor cells [12], and that this signaling is mediated by cytonemes.
We also analyzed the apical-basal organization of the disc cells by monitoring the distribu-
tion of Discs large (Dlg), which associates with the septate junction and localizes to the apical
compartment of the columnar epithelial cells. Sagittal optical sections of discs stained with
anti-Dlg antibody revealed that the specific apical distribution of Dlg characteristic of wild
type cells is disorganized in EGFR-Pcn tumor discs (Fig 3J and 3J’). Expression of diaRNAi in
the tumor cells restored the Dlg distribution to normal (Fig 3J”). This demonstrates that
expression of diaRNAi suppresses a critical feature of tumor cells and that downregulation of
Dia is compatible with normal cellular morphology and behavior.
Although EGFR and Pcn expression in the EGFR-Pcn model (driven by ap-Gal4) is
restricted to the dorsal compartment of the wing disc, the tumors grow extensively and metas-
tasize (Fig 4A). The tumorous condition is 100% lethal; animals with these tumors do not
Fig 3. Conditions that ablate cytonemes decrease signaling, reduce myoblast and tumor growth. (A-I) Fixed wing discs stained with α-phosphorylated MAD (pMad,
red) antibody to monitor Dpp signaling and α-Cut (cyan) to label myoblasts. Scale bars: 100μm. (A,A’) Control. (B,B’) EGFR-Pcn tumor, genotype: ap-Gal4,UAS-psqRNAi/
+;UAS-EGFR,tub-Gal80ts/UAS-CD8:GFP. (C,C’) Tumor + NrgRNAi, genotype: ap-Gal4,UAS-psqRNAi/UAS-NrgRNAi;UAS-EGFR,tub-Gal80ts/+. (D) Tumor + CapsDN,
genotype:ap-Gal4,UAS-psqRNAi/UAS-CAPSDN;UAS-EGFR,tub-Gal80ts/+. (E) Tumor + SCARRNAi, genotype:ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/
UAS-SCARRNAi. (F,F’) EGFR-Pcn + diaRNAi in epithelial cells. Genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/UAS-diaRNAi. (G) Tumor + NrgRNAi,
diaRNAi, genotype: ap-Gal4,UAS-psqRNAi/UAS-NrgRNAi;UAS-EGFR,tub-Gal80ts/UAS-diaRNAi. (I-I’) EGFR-Pcn + diaRNAi expressed in the myoblasts. Genotype: ap-
Gal4,UAS-psqRNAi/115B03-lexA;UAS-EGFR,tub-Gal80ts/ lexO-diaRNAi. (H) Quantification of the total wing disc area (blue) and relative area of Cut-expressing cells
(orange) of control, EGFR+Pcn tumor, tumor + diaRNAi expressed in epithelial cells, diaRNAi expressed in myoblasts, NrgRNAi, SCARRNAi, CapsDN, NrgRNAi
+diaRNAi, dsRNAi, ftRNAi, fjRNAi and BtlDN larvae. Data was normalized to control. Student’s t test P values (P>1.10−9 for all except no significant difference for
tumor + dsRNAi, ftRNAi and fjRNAi); n = 15–20 discs for each genotype. (J-J”) Sagittal sections of fixed wing discs stained with α-Dlg antibody (red) to mark the cell’s
apical compartments, Scale bar: 50μm. (J) Control. (J’) EGFR-Pcn tumor, genotype: ap-Gal4,UAS-psqRNAi/UAS-CD8:GFP;UAS-EGFR,tub-Gal80ts/+) (J”) EGFR-Pcn
+ diaRNAi expressed in epithelial cells, genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/UAS-diaRNAi.
https://doi.org/10.1371/journal.pgen.1008415.g003
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mature beyond the larval stage [12]. However, the conditions of Nrg, Caps, SCAR, or dia
downregulation that suppress tumor growth also suppressed lethality: the number of
EGFR-Pcn tumor-bearing larvae that pupated and that reached the pharate adult stage
increased, and for the animals that expressed diaRNAi, approximately 60% survived to adult
stage (Fig 4B). These surviving adults were fertile, and wing blade morphological defects were
the only visible phenotype (Fig 4C and 4D). Given that cytoneme-mediated signaling is
reduced by downregulation of Nrg, Caps, SCAR, or Dia, these results are consistent with the
possibility that cytoneme-mediated signaling is necessary for tumor growth and that interfer-
ing with signaling either between tumor cells or between tumor and stromal cells suppresses
many if not all aspects of tumorigenesis.
Bnl signaling in the EGFR-Pcn model
The disc-associated ASP branch of the tracheal system is dependent on and sensitive to signals
produced by the disc [25,26], and Bnl signaling from the disc to the ASP is cytoneme-mediated
and cytoneme-dependent [7,21]. Because tracheal branches grow excessively in the EGFR-Pcn
tumor model (Fig 1H), we investigated if Bnl signaling is upregulated in tumor discs. Bnl is
normally produced by a small, discrete group of disc cells (Fig 1A). Disc cells do not express
Btl, but tracheal cells express Btl and not Bnl [26]. To monitor Bnl signaling in the EGFR-Pcn
Fig 4. Conditions that ablate cytonemes promote survival. (A) Cartoon of a wild type larva depicting cells expressing
GFP in the imaginal disc dorsal compartments (ap-Gal4; green, arrow) and of EGFR-Pcn tumor larva with overgrowth
and metastasis throughout the larva (green). (B) Survival of EGFR-Pcn tumor, tumor + diaRNAi, NrgRNAi,
SCARRNAi and CapsDN larvae to pupal (blue), pharate adult (orange) and adult stage (gray). Student’s t test P values:
(between P<0.05 and P>1.10−8) with n = 15–30 larvae for each genotype. (C) Control adult wing. (D) EGFR-Pcn
+ diaRNAi wing, genotype: ap-Gal4,UAS-psqRNAi/UAS-CD8:GFP;UAS-EGFR,tub-Gal80ts/UAS-diaRNAi.
https://doi.org/10.1371/journal.pgen.1008415.g004
Tumor cytonemes
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008415 September 30, 2019 8 / 18
tumor model, we examined a Bnl reporter that expresses mCherry:CAAX in Bnl-expressing
cells [27]. The number and location of Bnl-expressing cells increased in tumor discs (Fig 5A
and 5B). We also examined fluorescence of Btl:mCherry (with a CRISPR-generated knock-in
[21]). Whereas Btl:mCherry fluorescence was not detected in the epithelial cells of normal
wing discs (Fig 5C and 5C’), Btl:mCherry fluorescence was present in many epithelial cells of
the tumor (Fig 5D and 5D’). These results are consistent with the possibility that the tumor
induces ectopic expression of Btl and that ectopic activation of the Bnl signaling pathway
might correlate with excessive growth of the tracheal branches in this tumor.
To investigate the role of Bnl signaling in EGFR-Pcn tumorigenesis, we overexpressed a
dominant negative FGFR mutant in the tumor cells to block Bnl signaling (UAS-BtlDN). We
monitored wing discs for morphology, Cut expression, and pMAD in EGFR-Pcn tumor discs,
and EGFR-Pcn tumor discs that also express BtlDN. Experimental crosses were carried out
with the regimen described previously and produced either tumor larvae or suppressed tumor
larvae; both crosses generate control (CyO balancer) and tumor-containing animals in a Men-
delian ratio of 1:1. In the cross with UAS-BtlDN, 50.6% (76/151) of the larvae pupated and
eclosed within 4 days as curly wing adults. The presence of the balancer chromosome indicates
that the genotype of these flies lacked ap-Gal4, as expected of control, non-tumor animals. The
remaining larvae do not develop beyond the pupal stage, consistent with their having the
tumor genotype. Larvae analyzed after 7 days of Gal4 expression at the non-permissive were
compared to tumor discs of the same age (Fig 1C). In the EGFR-Pcn tumor discs that also
express BtlDN, characteristics of tumor morphology, size, pattern of Dpp signaling, and distri-
bution of myoblasts were suppressed (Fig 5E and 5F).
To confirm the identity genotype of the suppressed tumor discs, RNA isolated from wild
type, EGFR-Pcn tumor, and BtlDN-expressing tumor discs was quantified by QPCR. This anal-
ysis confirmed the overexpression of EGFR in both tumor and suppressed tumor discs (Fig
5G). We also examined EGF and Bnl signal transduction in tumor and suppressed tumor discs
by staining with anti-dpERK antibody. The presence of dpERK was observed in control,
tumor, and BtlDN -over-expressing control and tumor discs, and whereas the pattern of
dpERK in the tumor discs was expanded and disordered in the tumor discs, the patterns and
levels in the suppressed discs was close to normal (Fig 5H–5K). These findings are consistent
with the idea that tracheogenesis is necessary for tumor growth and with a previous report that
describes comparable findings in studies of a lethal giant larvae Drosophila tumor model [28].
In this tumor, ectopic tracheal sprouting is associated with hypoxic responses and tracheal dif-
ferential of wing disc tumor cells, a process that may be analogous to “sprouting angiogenesis”
and vascular co-option in mammalian tumors [29].
Cytonemes in a RET-MEN2 tumor model
We investigated the role of cytonemes in the Drosophila RET-MEN2 tumor model developed
by the Cagan lab [14]. This model mimics the mis-regulation of signaling pathways that have
been implicated in MEN2-related tumors. Overexpression of RETMEN2 in a discrete set of
wing disc epithelial cells (with ptc-Gal4) resulted in a>4X increase in the number of ptc-
expressing cells and a 7X increase in the portion of the disc that consists of ptc-expressing cells
(Fig 6A and 6B) [14]. Approximately one-half of the animals survive to the pupal stage, but
none survive to adult. We tested whether expression of Irk2DN (an inwardly-rectifying potas-
sium channel required for cyteneme-mediated signaling [5]), diaRNAi, or SCARRNAi in the
RET-mutant cells affects tumor growth and survival. We observed that excessive growth of the
ptc-expressing cells was suppressed by more than 2X in all three genotypes (Fig 6C–6F).
Approximately two-thirds of the animals developed to the pupal stage, and survival to adult
Tumor cytonemes
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Fig 5. FGF signaling in the EGFR-Pcn tumor model. (A-B) Unfixed wing discs with Bnl-expressing cells marked with Cherry-CAAX (red,
arrows). (A) Control, genotype: bnl-lexA,lexO-mCherry:CAAX/+. Scale bar: 100μm. (B) EGFR-Pcn tumor, genotype: ap-Gal4,UAS-psqRNAi/+;
UAS-EGFR,tub-Gal80ts/bnl-lexA,lexO-mCherry:CAAX. Arrows indicate FGF up-regulation (red). (C-D’) Unfixed wing discs with Btl
distribution marked by Btl:mCherry (red, arrows). (C) Control, genotype: Btl:mCherry/+. Btl is only expressed in the tracheal cells. Scale bar:
100μm (C’) Higher magnification image of the boxed area in (C). (D) 5 day EGFR-Pcn tumor disc, genotype: ap-Gal4,UAS-psqRNAi/
UAS-CD4-mIFP;UAS-EGFR,tub-Gal80ts/Btl:mCherry. Btl expression is upregulated in the tumor cells. (D’) Higher magnification image of the
box area in (D). Scale bars: 50μm. (E-F) EGFR-Pcn tumor +BtlDN fixed wing disc stained with α-phosphorylated MAD (pMad, red) antibody
to monitor Dpp signaling (E) and α-Cut (cyan) to label myoblasts (F). Scale bar: 100μm. Genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-
Gal80ts/UAS-BtlDN. (G) EGFR mRNA measured by quantitative real-time PCR. RNA was extracted from 5 discs of the indicated genotypes.
Data were normalized to rp49. The data show mean ± SD from three technical replicates of a representative experiment. Significance was
analyzed using Student’s t-test (p<0.001). Comparable results were obtained in 3 independent biological replicates. Genotypes are ap-Gal4,
UAS-CD8:GFP (WT), ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/ UAS-CD8:GFP (tumor) and ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-
Gal80ts/UAS-BtlDN. (H-K) Fixed wing disc stained with α-phosphorylated ERK to monitor EGF signaling (dpERK, red). (H) Control,
Tumor cytonemes
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also increased (Fig 6G). These flies have normal morphology, and with the exception of small
wing vein abnormalities, the wings are indistinguishable from wild type (Fig 6H). These results
are consistent with a general role for cytonemes in tumorigenesis and tumor progression.
Discussion
The tumor microenvironment is a niche that responds to signaling proteins produced by
tumor cells and supplies growth factors that support tumor growth and metastasis [30]. Much
ongoing work seeks inhibitors of tumorigenesis that target the signaling molecules and growth
factors, their signal transduction pathways, and the stromal cells of the microenvironment
[31,32]. Two previous studies reported cellular extensions of human tumor cells in ex vivo co-
cultures with non-metastatic cells and in vivo, and have been implicated these structures in
material transfer between tumor and non-tumor cells [33,34]. In this work, we also investi-
gated the mechanism that transfers signaling molecules and growth factors between tumor
cells and stromal cells in vivo, and report the first evidence for their essential role in
tumorigenesis.
Previous work established that during Drosophila development, paracrine signaling by the
signaling proteins/growth factors Dpp, Bnl, Wg, Notch and Hedgehog, is mediated by cyto-
nemes [35–37]. Cytonemes are specialized filopodia that extend between signal producing and
signal receiving cells, making synaptic contacts where the signaling proteins transfer from pro-
ducing to receiving cells. To extend this work to tumorigenesis, we applied the strategies and
tools we developed for previous studies to ask if cytonemes are present in the tumor microen-
vironment, and if genetic conditions that inhibit cytoneme function and cytoneme-dependent
signaling in normal development also inhibit tumorigenesis. In a EFGR-Pcn tumor model, we
found that cytonemes extend from both Drosophila tumor and stromal cells (Fig 1). This is
consistent with previous studies that reported increased signaling between tumor and stromal
cells in this model [12], and with the presence of cytonemes in many other contexts of para-
crine signaling [7,18,20,38–41]. We confirmed that Dpp is expressed by the tumor cells (Fig 2;
[12]), and found that ectopic Bnl signaling also has an essential role in this tumor (Fig 5).
These results imply functional connections between the EGF, Dpp, and Bnl signaling pathways
in this tumor, and although we did not identify regulatory interactions between the pathways,
our results show that ectopic activation of the Bnl pathway is essential to tumorigenesis.
We also found conditions that impair cytonemes and rescue flies of lethal tumors in both
EGFR-Pcn and RET models. We selected five genes from among the more than twenty that
are known to be essential for cytoneme-mediated signaling [5,7,18,19]. nrg, caps, Irk2, SCAR,
and dia are recessive lethal genes whose functions can be partially reduced in genetic mosaics
without affecting viability, cell shape, or the cell cycle, but are necessary for cytoneme function.
Downregulating any one of these genes improved viability in the tumor models. dia downre-
gulation is the most effective inhibitor of cytoneme-mediated signaling in other contexts
[7,19,20], and it is the most effective in both tumor models. The cures that downregulation
effected suggest that cytoneme-mediated signaling, which might be a general mechanism for
tumorigenesis in a variety of cancers, might also be a potential target for therapy.
The high degree of evolutionary conservation of Drosophila and human proteins makes
Drosophila a clinically relevant platform for understanding mechanisms human disease, and
Drosophila tumor models have successfully identified new therapeutic candidates for
genotype: ap-Gal4,UAS-CD8:GFP. (I) Control+BtlDN, genotype: ap-Gal4/+;UAS-BtlDN/+. (I) EGFR-Pcn tumor disc, genotype: ap-Gal4,UAS-
psqRNAi/+;UAS-EGFR,tub-Gal80ts/ UAS-CD8:GFP. EGFR-Pcn tumor + BtlDN, genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/
UAS-BtlDN.
https://doi.org/10.1371/journal.pgen.1008415.g005
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colorectal, lung and thyroid and stem-cells derived cancers [42–44]. Our work provides proof
principle for tumor suppression by interfering with cytoneme-mediated signaling.
Materials and methods
Drosophila stocks and husbandry
Flies were reared on standard cornmeal and agar medium at 29˚C, unless otherwise stated. ap-
Gal4 UAS-psqRNAi/CyO; UAS-EGFR tub-Gal80ts from S. Cohen [12], UAS-RETMEN2 from R.
Fig 6. RET-MEN2 tumor growth and survival depends on cytonemes. (A-B’) Unfixed wing discs expressing CD8:
GFP (green) driven by ptc-Gal4. Scale bar: 100μm. (A) Control. (A’) Cytonemes in wild type cells (green, arrows). Scale
bar: 50μm. (B) RET tumor, genotype: ptc-Gal4,CD8:GFP;UAS-RETMEN2/UAS-CD8:GFP. (B’) Cytonemes in RET
tumor cells (green, arrows). (C-E) Unfixed wing discs expressing CD8:GFP (green) and either RET + diaRNAi (C);
RET + SCARRNAi (D); and RET + Irk2DN (E). (C) Genotype: ptc-Gal4,CD8:GFP;UAS-RETMEN2/UAS-diaRNAi. (D)
Genotype: ptc-Gal4,CD8:GFP;UAS-RETMEN2/UAS-SCARRNAi. (E) Genotype: ptc-Gal4,CD8:GFP/Irk2DN ;
UAS-RETMEN2. (F) Quantification of the area of the disc expressing GFP (% of disc) in control, RET tumor, or RET
and either diaRNAi, SCARRNAi or Irk2DN. Significance was analyzed using Student’s t-test (P<1.10−5) with 15–18
discs. (G) Survival of RET-tumor and RET and either diaRNAi, SCARRNAi or Irk2DN to pupa (blue) and adult
(orange). Significance using Student’s t-test for adults is (P<0.001), n = 30–40 for each genotype. (H) RET tumor,
diaRNAi wing blade; genotype: ptc-Gal4,CD8:GFP;UAS-RETMEN2/UAS-diaRNAi. Arrow points to abnormal crossvein.
https://doi.org/10.1371/journal.pgen.1008415.g006
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Cagan [14], Btl:mCherry and Bnl-lexA, from S. Roy [21,27], lexO-diaRNAi from H. Huang,
UAS-CapsDN [45] (deletion mutant lacking the intracellular domain), UAS-BtlDN from B.
Shilo [46] (dominant negative construct lacking a functional cytoplasmic tyrosine-kinase
domain), Irk2DN from E. Bates [47] (a subunit predicted to block the channel). btl-LHG,lex-
O-CD2:GFP, a tracheal-specific driver [16]; ptc-Gal4 enhancer is an enhancer trap line that
mimics ptc expression [48], lexO-mCherry:CAAX from K. Basler; lines from Bloomington
Stock Center: 15B03-lexA (#52486), UAS-CD8:GFP (#5137), UAS-diaRNAi (#28541 and
#35479), UAS-NrgRNAi (#37496), UAS-dsRNAi (#32964), UAS-ftRNAi (#34970), UAS-fjRNAi
(#34323); and UAS-SCARRNAi (#21908) from Vienna Drosophila Research Center Stock
Center.
Dpp:mCherry
The Dpp:mCherry transgene has mCherry inserted C-terminal to Dpp amino acid 465 [17],
with Leu-Val linkers inserted before and after a mCherry coding sequence deleted of its stop
codon. The transgene was generated by CRISPR mutagenesis as follows:
Dpp:mCherry donor vector
Left homology arm fragment contains overlapping sequence with PBS-SK vector and
mCherry. The mCherry fragment contains overlapping sequence with the left homology arm
and right homology arm. The right homology arm fragment contains overlapping sequence
with mCherry and PBS-SK vector. The three fragments were stitched together and cloned into
PBS-SK vector using Gibson Assembly (NEB). The resulting vector is designated as Dpp:
Cherry donor vector.
Left arm homology sequence was amplified from wild-type genomic DNA using:
L-arm-fwd: cggtatcgataagcttgatcaccttgccgcacaaatacatatac
L-arm-rev: CCTCGCCCTTGCTCACCATCTCCAGGCCACCGCCCTCTCCGGCAGCA
CGTCCCGA
The mCherry tag was amplified using:
mCherry-fwd:TGTCTGCCGGAGAGGGCGGTGGCCTGGAGATGGTGAGCAAGGGC
GAGGAGGATAAC
Cherry-rev:CGCTTGTTCCGGCCGCCCTTCTCTAACTTGTACAGCTCGTCCATGC
CGC
The right arm homology sequence was amplified from wild-type genomic DNA using:
R-arm-fwd:GGACGAGCTGTACAAGTTAGAGAAGGGCGGCCGGAACAAGCGGCAG
CCGA
R-arm-rev:ccgggctgcaggaattcgatGTCATTATTCGGTTATGCTCTCGCTAG
pCFD-3 gRNA vector
gRNA sequence: CGCTCCATTCGGGACGTGTCTGG
The gRNA sequence without the PAM was cloned into pCFD-3 vector obtained from
Addgene.
Dpp:Cherry CISPR lines
pCFD-3 gRNA vector and Dpp:mCherry donor vector were co-injected into Cas9 expressing
flies (nanos-Cas9) by Rainbow Transgenics. The resulting CRISPR-generated flies were
screened and verified by sequencing. The Dpp:mCherry homozygous fly is viable and has nor-
mal morphology. The distribution of Cherry fluorescence in the wing disc is consistent with
images in [17,49], and the gradient of Cherry fluorescence in the columnar epithelial cells of
the disc is intracellular (S1 Fig).
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EGFR-Pcn tumor
EGFR-Pcn tumors were induced as described by Herranz et al, [12] by overexpression of
EGFR and down-regulation of pipsqueak (psq), which leads to increased levels of Pcn. Female
flies from the stock ap-Gal4,UAS-psqRNAi/CyO;UAS-EGFR,tub-Gal80ts were crossed to males
of the corresponding genotypes at 18˚C, and were cultured at 18˚C to maintain Gal80 repres-
sion of Gal4 and allow normal development. After 5 days larvae were transferred to 29˚C to
induce Gal4 expression and tumor growth. 4 days after the temperature shift CyO/+ flies
eclosed and were removed from the vial. Tumor growth was induced for 7 days, unless other-
wise indicated, whereupon larvae were dissected for live imaging or immunostaining, or were
maintained at 29˚C for survival studies. To control for possible effects on Gal4 expression, all
tested genotypes had three UAS transgenes–either UAS-EGFR, UAS-psqRNAi and UAS-CD8:
GFP for tumor flies, or UAS-EGFR, UAS-psqRNAi and additional RNAi for comparisons.
Experimental and control crosses were carried out in parallel.
RET tumor model
Female flies from the RETMEN2 stock [14] were crossed at room temperature to either ptc-
Gal4, 2xUAS-CD8:GFP males or either with UAS-diaRNAi, or SCARRNAi or Irk2DN males.
For analysis of discs, embryos from one day collections were transferred to 29˚C and cultured
to third instar stage. For survival comparisons, animals were cultured at 25˚C.
Live imaging of wing imaginal discs
Wing discs with trachea attached were dissected in cold phosphate-buffered saline (PBS),
placed on a coverslip and mounted upside-down on a coverslip on a depression slide as
described [9]. Samples were imaged with a Leica TCS SPE confocal or an Olympus FV3000
inverted confocal laser scanning microscope.
Immunohistochemistry
Wing discs were dissected in cold PBS and fixed in 4% formaldehyde for 20 minutes. After
extensive washing, the samples were permeablized with PBST (PBS + 0.3% TritonX-100),
blocked for 1h with PBST+3%BSA blocking buffer, and incubated with primary antibodies
previously diluted in blocking buffer overnight at 4˚C. The following primary antibodies were
used: α-pMad (Abcam), α-Discs large (Dlg), α-Cut and α-β-galactosidase (Developmental
Studies Hybridoma Bank). Secondary antibodies were conjugated to Alexa Fluor 405, 488,
555, or 647. Samples were mounted in Vectashield and imaged with a Leica TCS SPE confocal
or an Olympus FV3000 inverted confocal laser scanning microscope.
Image analysis and quantification
All measurements and quantifications of wing discs were done in z-section stacks of confocal
images using Fiji software from 15–20 discs for each genotype. Total wing disc area and Cut-
expressing cells in the EGFR-Pcn tumor or GFP-expressing cells in the RET tumor, were quan-
tified by measuring the mean intensity of fluorescence relative to the total area of the wing
disc. Data was normalized to control. Statistical significance values were calculated with Stu-
dent’s t test.
Quantitative real-time PCR
Total RNA was extracted from 5 wing discs of either wild type, EGFR-Pcn tumor or EGFR-Pcn
tumor + BtlDN larvae using the RNeasy Micro Kit (Quiagen). Larvae corresponding from 3
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genotypes were under the same temperature conditions (5 days of tumor induction at 29˚C).
Reverse transcription was carried out using the Applied Biosystem High Capacity RNA-to-
cDNA. qPCR reactions were performed with a BioRad C1000 Touch Thermal Cycler and
SYBR Green (Bioline). qPCR results were analyzed according to the comparative threshold
cycle (Ct) method, where the amount of target, normalized to an endogenous actin reference
and relative to an experimental control, is given by 2–ΔΔCt. Ct represents the PCR cycle num-
ber at which the amount of target reaches a fixed threshold. The ΔCt value is determined by
subtracting the reference Ct value (rp49) from the target Ct value. ΔCt was calculated by sub-
tracting the ΔCt experimental control value.
Supporting information
S1 Fig. Dpp:mCherry distribution in the wing disc. Wing discs from a L3 larva with the
CRISPR-generated Dpp:mCherry allele stained with phalloidin (green) to mark the cells. Fron-
tal section shows Cherry fluorescence extending anteriorly and posteriorly from the band of
Dpp expression. Orthogonal section shows that the Cherry fluorescence in the cells outside the
band of Dpp expression is intracellular.
(TIF)
S2 Fig. Conditions that don’t ablate cytonemes do not reduce tumor growth. (A) Unfixed
wing disc with marked tracheal cells (green). Genotype: ap-Gal4,UAS-psqRNAi/btl-LHG,lex-
O-CD2-GFP;UAS-EGFR,tub-Gal80ts/UAS-diaRNAi. (B-D) Fixed wing discs stained with α-
pMad (red) antibody to monitor Dpp signaling and α-Cut (cyan) to label myoblasts. Scale bar:
100μm. (B-B’) Tumor + fjRNAi, genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-Gal80ts/
UAS-fjRNAi. (C-C’) Tumor + dsRNAi, genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,tub-
Gal80ts/UAS-dsRNAi. (D-D’) Tumor + ftRNAi, genotype: ap-Gal4,UAS-psqRNAi/+;UAS-EGFR,
tub-Gal80ts/UAS-ftRNAi.
(TIF)
Acknowledgments
We thank: Dr. Manolo Calleja for initiating this study, Drs. S. Cohen, H. Herranz, S. Roy, and
R. Cagan and Bloomington Stock Center for fly stocks and R. Cagan for his help and advice;
all members of Kornberg lab for discussion and constructive suggestions.
Author Contributions
Conceptualization: Sol Fereres, Ryo Hatori, Thomas B. Kornberg.
Data curation: Sol Fereres.
Funding acquisition: Thomas B. Kornberg.
Investigation: Sol Fereres, Ryo Hatori.
Methodology: Sol Fereres, Ryo Hatori.
Project administration: Thomas B. Kornberg.
Resources: Makiko Hatori.
Supervision: Thomas B. Kornberg.
Validation: Sol Fereres.
Visualization: Sol Fereres, Ryo Hatori.
Tumor cytonemes
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008415 September 30, 2019 15 / 18
Writing – original draft: Sol Fereres, Thomas B. Kornberg.
Writing – review & editing: Sol Fereres, Thomas B. Kornberg.
References
1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57–70. https://doi.org/10.1016/
s0092-8674(00)81683-9 PMID: 10647931
2. Roswall P, Bocci M, Bartoschek M, Li H, Kristiansen G, Jansson S, et al. Microenvironmental control of
breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. Nature
Medicine. 2018; 24: 463–473. https://doi.org/10.1038/nm.4494 PMID: 29529015
3. Pietras K, O¨ stman A. Hallmarks of cancer: Interactions with the tumor stroma. Experimental Cell
Research. 2010. pp. 1324–1331. https://doi.org/10.1016/j.yexcr.2010.02.045 PMID: 20211171
4. Sonoshita M, Cagan RL. Modeling Human Cancers in Drosophila. Current topics in developmental biol-
ogy. 2017. pp. 287–309. https://doi.org/10.1016/bs.ctdb.2016.07.008 PMID: 28057303
5. Huang H, Liu S, Kornberg TB. Glutamate signaling at cytoneme synapses. Science. 2019; 363: 948–
955. https://doi.org/10.1126/science.aat5053 PMID: 30819957
6. Kornberg TB, Roy S. Communicating by touch—neurons are not alone. Trends Cell Biol. 2014; 24:
370–376. https://doi.org/10.1016/j.tcb.2014.01.003 PMID: 24560610
7. Roy S, Huang H, Liu S, Kornberg TB. Cytoneme-Mediated Contact-Dependent Transport of the Dro-
sophila Decapentaplegic Signaling Protein. Science. 2014; 343: 1244624–1244624. https://doi.org/10.
1126/science.1244624 PMID: 24385607
8. Gonza´lez-Me´ndez L, Seijo-Barandiara´n I, Guerrero I. Cytoneme-mediated cell-cell contacts for hedge-
hog reception. eLife. 2017;6. https://doi.org/10.7554/eLife.24045 PMID: 28825565
9. Huang H, Kornberg TB. Myoblast cytonemes mediate Wg signaling from the wing imaginal disc and
Delta-Notch signaling to the air sac primordium. eLife. 2015; 4: e06114. https://doi.org/10.7554/eLife.
06114 PMID: 25951303
10. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. The epidermal growth
factor receptor: From development to tumorigenesis. Differentiation. 2007. pp. 770–787. https://doi.org/
10.1111/j.1432-0436.2007.00238.x PMID: 17999740
11. Jiang X, Couchman JR. Perlecan and Tumor Angiogenesis. Journal of Histochemistry and Cytochemis-
try. 2003. pp. 1393–1410. https://doi.org/10.1177/002215540305101101 PMID: 14566013
12. Herranz H, Weng R, Cohen SM. Crosstalk between epithelial and mesenchymal tissues in tumorigene-
sis and imaginal disc development. Current Biology. 2014; 24: 1476–1484. https://doi.org/10.1016/j.
cub.2014.05.043 PMID: 24980505
13. Read RD, Goodfellow PJ, Mardis ER, Novak N, Armstrong JR, Cagan RL. A drosophila model of multi-
ple endocrine neoplasia type 2. Genetics. 2005; 171: 1057–1081. https://doi.org/10.1534/genetics.104.
038018 PMID: 15965261
14. Dar AC, Das TK, Shokat KM, Cagan RL. Chemical genetic discovery of targets and anti-targets for can-
cer polypharmacology. Nature. 2012; 486: 80–84. https://doi.org/10.1038/nature11127 PMID:
22678283
15. Kornberg TB. Cytonemes and the dispersion of morphogens. Wiley Interdisciplinary Reviews: Develop-
mental Biology. 2014. pp. 445–463. https://doi.org/10.1002/wdev.151 PMID: 25186102
16. Shiga Y, Tanaka-Matakatsu M, Hayashi S. A nuclear GFP/beta-galactosidase fusion protein as a
marker for morphogenesis in living Drosophila. Development Growth & Differentiation. 1996; 38: 99–
106. https://doi.org/10.1046/j.1440-169X.1996.00012.x
17. Entchev E V, Schwabedissen A, Gonza´lez-Gaita´n M. Gradient formation of the TGF-beta homolog
Dpp. Cell. 2000; 103: 981–91. https://doi.org/10.1016/s0092-8674(00)00200-2 PMID: 11136982
18. Bischoff M, Gradilla AC, Seijo I, Andres G, Rodriguez-Navas C, Gonzalez-Mendez L, et al. Cytonemes
are required for the establishment of a normal Hedgehog morphogen gradient in Drosophila epithelia.
Nat Cell Biol. 2013; 15: 1269–1281. https://doi.org/10.1038/ncb2856 PMID: 24121526
19. Huang H, Kornberg TB. Cells must express components of the planar cell polarity system and extracel-
lular matrix to support cytonemes. eLife. 2016;5. https://doi.org/10.7554/eLife.18979 PMID: 27591355
20. Chen W, Huang H, Hatori R, Kornberg TB. Essential basal cytonemes take up Hedgehog in the Dro-
sophila wing imaginal disc. Development. 2017; https://doi.org/10.1242/dev.149856 PMID: 28743798
21. Du L, Sohr A, Yan G, Roy S. Feedback regulation of cytoneme-mediated transport shapes a tissue-spe-
cific FGF morphogen gradient. eLife. 2018; 7. https://doi.org/10.7554/eLife.38137 PMID: 30328809
Tumor cytonemes
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008415 September 30, 2019 16 / 18
22. Gonza´lez-Me´ndez L, Seijo-Barandiara´n I, Guerrero I. Cytoneme-mediated cell-cell contacts for Hedge-
hog reception. Elife. 2017;6. https://doi.org/10.7554/eLife.24045 PMID: 28825565
23. Blochlinger K, Jan LY, Jan YN. Postembryonic patterns of expression of cut, a locus regulating sensory
organ identity in Drosophila. Development (Cambridge, England). 1993; 117: 441–50. https://doi.org/
10.1101/gad.5.7.1124
24. Sharma P, McNeill H. Fat and Dachsous Cadherins. Progress in Molecular Biology and Translational
Science. 2013; 116: 215–235. https://doi.org/10.1016/B978-0-12-394311-8.00010-8 PMID: 23481197
25. Guha A, Lin L, Kornberg TB. Regulation of Drosophila matrix metalloprotease Mmp2 is essential for
wing imaginal disc:trachea association and air sac tubulogenesis. Developmental Biology. 2009; 335:
317–326. https://doi.org/10.1016/j.ydbio.2009.09.005 PMID: 19751719
26. Sato M, Kornberg TB. FGF is an essential mitogen and chemoattractant for the air sacs of the Drosoph-
ila tracheal system. Developmental Cell. 2002; 3: 195–207. https://doi.org/10.1016/S1534-5807(02)
00202-2 PMID: 12194851
27. Du L, Zhou A, Patel A, Rao M, Anderson K, Roy S. Unique patterns of organization and migration of
FGF-expressing cells during Drosophila morphogenesis. Developmental Biology. 2017; 427: 35–48.
https://doi.org/10.1016/j.ydbio.2017.05.009 PMID: 28502613
28. Grifoni D, Sollazzo M, Fontana E, Froldi F, Pession A. Multiple strategies of oxygen supply in Drosophila
malignancies identify tracheogenesis as a novel cancer hallmark. Sci Rep. 2015; 5: 9061. https://doi.
org/10.1038/srep09061 PMID: 25762498
29. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;
473: 298–307. https://doi.org/10.1038/nature10144 PMID: 21593862
30. Quail D, Joyce J. Microenvironmental regulation of tumor progression and metastasis. Nature medicine.
2013; 19: 1423–1437. https://doi.org/10.1038/nm.3394 PMID: 24202395
31. Presta M, Chiodelli P, Giacomini A, Rusnati M, Ronca R. Fibroblast growth factors (FGFs) in cancer:
FGF traps as a new therapeutic approach. Pharmacology and Therapeutics. 2017. pp. 171–187.
https://doi.org/10.1016/j.pharmthera.2017.05.013 PMID: 28564583
32. Heinemann V, Reni M, Ychou M, Richel DJ, Macarulla T, Ducreux M. Tumour-stroma interactions in
pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies. Can-
cer Treatment Reviews. 2014. pp. 118–128. https://doi.org/10.1016/j.ctrv.2013.04.004 PMID:
23849556
33. Lou E, Zhai E, Sarkari A, Desir S, Wong P, Iizuka Y, et al. Cellular and Molecular Networking Within the
Ecosystem of Cancer Cell Communication via Tunneling Nanotubes. Frontiers in cell and developmen-
tal biology. 2018; 6: 95. https://doi.org/10.3389/fcell.2018.00095 PMID: 30333973
34. Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, et al. Physical nanoscale conduit-
mediated communication between tumour cells and the endothelium modulates endothelial phenotype.
Nature Communications. 2015; https://doi.org/10.1038/ncomms9671 PMID: 26669454
35. Yamashita YM, Inaba M, Buszczak M. Specialized Intercellular Communications via Cytonemes and
Nanotubes. Annu Rev Cell Dev Biol. 2018; 34: 59–84. https://doi.org/10.1146/annurev-cellbio-100617-
062932 PMID: 30074816
36. Gonza´lez-Me´ndez L, Gradilla A-C, Guerrero I. The cytoneme connection: direct long-distance signal
transfer during development. Development. 2019;146. https://doi.org/10.1242/dev.174607 PMID:
31068374
37. Kornberg TB. A Path to Pattern. Curr Top Dev Biol. 2016; 116: 551–567. https://doi.org/10.1016/bs.
ctdb.2015.11.026 PMID: 26970641
38. Eom DS, Bain EJ, Patterson LB, Grout ME, Parichy DM. Long-distance communication by specialized
cellular projections during pigment pattern development and evolution. eLife. 2015;4. https://doi.org/10.
7554/eLife.12401 PMID: 26701906
39. Sanders TA, Llagostera E, Barna M. Specialized filopodia direct long-range transport of SHH during
vertebrate tissue patterning. Nature. 2013; 497: 628–632. https://doi.org/10.1038/nature12157 PMID:
23624372
40. Stanganello E, Hagemann AIH, Mattes B, Sinner C, Meyen D, Weber S, et al. Filopodia-based Wnt
transport during vertebrate tissue patterning. Nature communications. 2015; 6: 5846. https://doi.org/10.
1038/ncomms6846 PMID: 25556612
41. Inaba M, Buszczak M, Yamashita YM. Nanotubes mediate niche-stem-cell signalling in the Drosophila
testis. Nature. 2015; 523: 329–332. https://doi.org/10.1038/nature14602 PMID: 26131929
42. Bangi E, Murgia C, Teague AGS, Sansom OJ, Cagan RL. Functional exploration of colorectal cancer
genomes using Drosophila. Nature Communications. 2016;7. https://doi.org/10.1038/ncomms13615
PMID: 27897178
Tumor cytonemes
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008415 September 30, 2019 17 / 18
43. Levine BD, Cagan RL. Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate
Therapeutic. Cell Reports. 2016; https://doi.org/10.1016/j.celrep.2015.12.105 PMID: 26832408
44. Markstein M, Dettorre S, Cho J, Neumuller RA, Craig-Muller S, Perrimon N. Systematic screen of che-
motherapeutics in Drosophila stem cell tumors. Proceedings of the National Academy of Sciences.
2014; 111: 4530–4535. https://doi.org/10.1073/pnas.1401160111 PMID: 24616500
45. Taniguchi H, Shishido E, Takeichi M, Nose A. Functional dissection of Drosophila Capricious: Its novel
roles in neuronal pathfinding and selective synapse formation. Journal of Neurobiology. 2000; 42: 104–
116. https://doi.org/10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V PMID:
10623905
46. Reichman-Fried M, Shilo BZ. Breathless, a Drosophila FGF receptor homolog, is required for the onset
of tracheal cell migration and tracheole formation. Mechanisms of Development. 1995; https://doi.org/
10.1016/0925-4773(95)00407-R
47. Dahal GR, Pradhan SJ, Bates EA. Inwardly rectifying potassium channels influence Drosophila wing
morphogenesis by regulating Dpp release. Development. 2017; 144: 2771–2783. https://doi.org/10.
1242/dev.146647 PMID: 28684627
48. Ramirez-Weber FA, Casso DJ, Aza-Blanc P, Tabata T, Kornberg TB. Hedgehog signal transduction in
the posterior compartment of the Drosophila wing imaginal disc. Molecular Cell. 2000; 6: 479–485.
https://doi.org/10.1016/s1097-2765(00)00046-0 PMID: 10983993
49. Teleman AA, Cohen SM. Dpp gradient formation in the Drosophila wing imaginal disc. Cell. 2000; 103:
971–980. https://doi.org/10.1016/s0092-8674(00)00199-9 PMID: 11136981
Tumor cytonemes
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008415 September 30, 2019 18 / 18
